Aprecia Pharmaceuticals Company:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Aprecia Pharmaceuticals Company - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0470
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aprecia Pharmaceuticals Company (Aprecia) is a drug delivery technology platform company that develops pharmaceutical drug products. The company offers Zipdose technology, a delivery platform that serves as the foundation of orodispersible formulations of prescribed high-dose medications. It also provides 3D printing technology platform that uses an aqueous fluid to stitch together multiple layers of powder using patent-protected process. Aprecia offers SPRITAM levetiracetam tablet for oral use as a prescription adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures in adults and children with epilepsy. The company has operations in Pennsylvania, New Jersey and Ohio, the US. Aprecia is headquartered in Langhorne, Pennsylvania, the US.

Aprecia Pharmaceuticals Company – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aprecia Pharmaceuticals Company, Medical Devices Deals, 2012 to YTD 2018 9
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Aprecia Pharma Raises Funds in Financing Round 11
Aprecia Pharma Raises USD35 Million in Preferred Stock Financing 12
Aprecia Pharma Raises US$15 Million In Venture Financing 13
Aprecia Pharma Raises US$4 Million In Venture Financing 14
Partnerships 15
Aprecia Pharma and Cycle Pharma Enter into Agreement 15
Acquisition 16
Prasco Laboratories Acquires Additional stake in Aprecia Pharma 16
Aprecia Pharmaceuticals Company – Key Competitors 17
Aprecia Pharmaceuticals Company – Key Employees 18
Aprecia Pharmaceuticals Company – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Nov 01, 2017: Aprecia Pharmaceuticals Names University of Kentucky Provost as the Company’s Next CEO 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Key Facts 2
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aprecia Pharmaceuticals Company, Deals By Therapy Area, 2012 to YTD 2018 8
Aprecia Pharmaceuticals Company, Medical Devices Deals, 2012 to YTD 2018 9
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aprecia Pharma Raises Funds in Financing Round 11
Aprecia Pharma Raises USD35 Million in Preferred Stock Financing 12
Aprecia Pharma Raises US$15 Million In Venture Financing 13
Aprecia Pharma Raises US$4 Million In Venture Financing 14
Aprecia Pharma and Cycle Pharma Enter into Agreement 15
Prasco Laboratories Acquires Additional stake in Aprecia Pharma 16
Aprecia Pharmaceuticals Company, Key Competitors 17
Aprecia Pharmaceuticals Company, Key Employees 18
Aprecia Pharmaceuticals Company, Other Locations 19

List of Figures
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aprecia Pharmaceuticals Company, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Aprecia Pharmaceuticals Company:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Soma Bay Development Company S.A.E.:企業の戦略・SWOT・財務分析
    Soma Bay Development Company S.A.E. - Strategy, SWOT and Corporate Finance Report Summary Soma Bay Development Company S.A.E. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Acelity Holdings, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Acelity Holdings Inc (Acelity) is a medical technology company engaged in developing wound care and regenerative medicine solutions. The company offers various solutions such as incision management, open abdomen management, epidermal harvesting and animal health. Acelity through its subsidia …
  • GETECH Group plc (GTC):企業の財務・戦略的SWOT分析
    Summary Getech Group Plc (Getech) is an oil and gas service company that offers geological and geophysical services. The company’s services include regional reports, globe, commissions and global gravity and magnetic data solutions. Its in-house specialties comprise airborne geophysics, potential fi …
  • TPI Composites Inc (TPIC):企業の財務・戦略的SWOT分析
    TPI Composites Inc (TPIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cleco Corporate Holdings, LLC:戦略・SWOT・企業財務分析
    Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report Summary Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Wellcome Trust:企業のM&A・事業提携・投資動向
    Wellcome Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wellcome Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Electricity Generation Company of Bangladesh Ltd:企業の戦略的SWOT分析
    Electricity Generation Company of Bangladesh Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • The Hain Celestial Group Inc (HAIN):企業の財務・戦略的SWOT分析
    The Hain Celestial Group Inc (HAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • University of Oxford-製薬・医療分野:企業M&A・提携分析
    Summary University of Oxford (UO) is a research and educational university that offers student training, academic research and graduation programs. The university offers graduation courses in the various fields such as humanities, mathematical, physical and life sciences; medical sciences, and conti …
  • EWE AG:企業の戦略的SWOT分析
    EWE AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Tong Ren Tang Technologies Co Ltd (1666):企業の財務・戦略的SWOT分析
    Summary Tong Ren Tang Technologies Co Ltd (TRTT), a subsidiary of Beijing Tong Ren Tang Co Ltd is a pharmaceutical company that manufactures and supplies Chinese medicines. The company’s products comprise Chinese medicine, healthy food and maier hai cosmetics. It offers products in the forms of pill …
  • Volkswagen AG (VOW3)-エネルギー分野:企業M&A・提携分析
    Summary Volkswagen AG (Volkswagen) is an automobile company involved in the design, development, production and sales of a wide range of vehicles and engines. It commercializes both passenger and commercial vehicles, including low consumption small cars and luxury class vehicles. The company sells i …
  • ION Geophysical Corp (IO):石油・ガス:M&Aディール及び事業提携情報
    Summary ION Geophysical Corp (ION) is a provider of seismic solutions. It offers geoscience products, services and solutions to the global oil and gas industry. The company acquires, process and interpret data from seismic surveys in regional data programs, which become part of the multi-client data …
  • Hilcorp Energy Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Hilcorp Energy Co (Hilcorp) is an oil and natural gas exploration and production company. The company acquires and exploits conventional assets. It offers services such as employee services, engineering and geological programs and operational programs. Hilcorp has operations in the gulf coas …
  • BNP Paribas SA:企業のM&A・事業提携・投資動向
    BNP Paribas SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BNP Paribas SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Verona Pharma Plc (VRP):医療機器:M&Aディール及び事業提携情報
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • Sanofi India Ltd (SANOFI):企業の財務・戦略的SWOT分析
    Summary Sanofi India Ltd (Sanofi India), formerly Aventis Pharma Ltd, a subsidiary of Sanofi is a healthcare company. It manufactures and markets pharmaceutical and prescription products. The company offers products in the form of capsules, tablets, injection, vials, ampoules, ointments, creams and …
  • Trimble Inc:企業の戦略・SWOT・財務情報
    Trimble Inc - Strategy, SWOT and Corporate Finance Report Summary Trimble Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Ricoh Company, Ltd.:企業の戦略・SWOT・財務分析
    Ricoh Company, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ricoh Company, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PCM Inc:戦略・SWOT・企業財務分析
    PCM Inc - Strategy, SWOT and Corporate Finance Report Summary PCM Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆